Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01558128 · ClinicalTrials.gov registry record · NA
Combined Amiodarone and Electrical Cardioversion for Postoperative Atrial Fibrillation After Cardiac Surgery
A NA study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01558128 is a NA study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 1 participants.
The verdict
NCT01558128, a NA study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
To determine the efficacy of cardioversion and amiodarone for cardiac patients who develop postoperative atrial fibrillation
Interventions
- DRUG Amiodarone
- PROCEDURE Cardioversion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01558128
The ClinicalTrials.gov registry entry for NCT01558128 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Amiodarone is the first listed.
NCT01558128 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01558128 about?
NCT01558128 is a clinical study titled "Combined Amiodarone and Electrical Cardioversion for Postoperative Atrial Fibrillation After Cardiac Surgery". To determine the efficacy of cardioversion and amiodarone for cardiac patients who develop postoperative atrial fibrillation
What is the current status of trial NCT01558128?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2012-03. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01558128?
The interventions under investigation include: Amiodarone (DRUG), Cardioversion (PROCEDURE).
Who is sponsoring clinical trial NCT01558128?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.